C‐reactive protein is significantly associated with prostate‐specific antigen and metastatic disease in prostate cancer

Abstract

The strong association of CRP with PSA, independent of tumour stage, suggests that inflammation might be fundamental in prostate cancer, and that chronic inflammation may be a legitimate target for prostate cancer chemoprevention and treatment.